These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9061169)

  • 1. Immunological transformations in the recipient of grafted allogeneic human bone.
    Hofmann GO; Falk C; Wangemann T
    Arch Orthop Trauma Surg; 1997; 116(3):143-50. PubMed ID: 9061169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic vascularized grafting of human knee joints under postoperative immunosuppression of the recipient.
    Hofmann GO; Kirschner MH; Wagner FD; Brauns L; Gonschorek O; Bühren V
    World J Surg; 1998 Aug; 22(8):818-23. PubMed ID: 9673553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunosuppressive effect of fresh allogeneic bone graft in mice.
    Miura K; Isobe K; Ueda A; Ishiguro N; Iwata H; Nakashima I; Miura T
    Int Orthop; 1997; 21(2):122-6. PubMed ID: 9195268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific tolerance induction in composite tissue allografts.
    Foster RD; Fan L; Neipp M; Kaufman C; McCalmont T; Ascher N; Ildstad S; Anthony JP; Niepp M
    Am J Surg; 1998 Nov; 176(5):418-21. PubMed ID: 9874425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 9. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
    Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
    Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
    [No Abstract]   [Full Text] [Related]  

  • 11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status of recipients following bone marrow-augmented solid organ transplantation.
    Zeevi A; Pavlick M; Lombardozzi S; Banas R; Pappo O; Rao AS; Fontes P; Demetris J; Shapiro R; Dodson F
    Transplantation; 1995 Feb; 59(4):616-20. PubMed ID: 7878767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
    Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N
    Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.